Age-dependent prevalence and clinical features of migraine

Background: Available data suggest two seemingly opposite trends with regard to the natural history of migraine. Migraine prevalence decreases with age. In some individuals, migraine progresses to chronic daily headache. Objective: To contrast the clinical features of migraine across the life span. Methods: A validated computer-assisted telephone interview (CATI) was used to identify a population sample in three urban centers in the United States. Eligible participants were older than 18 years. The CATI covered the International Classification of Headache Disorders criteria for migraine and probable migraine (PM). Prevalence and clinical features of migraine and PM were examined by age. Results: This sample consists of 145,335 participants. The overall prevalence of migraine was 15%, whereas the overall prevalence of PM was 14.6%. Migraine prevalence was highest between ages 30 and 39 years. In older ages, PM was more prevalent than migraine. Among those with migraine, the prevalence of unilateral and throbbing pain peaked at intermediate ages and declined after that. The prevalence of photophobia and phonophobia related to the attacks declined with ages, whereas the prevalence of aura increased. The proportion of those with 10 to 14 headache days per month also increased, from 12.5% in those ages 18 to 29 to 41.0% (odds ratio = 4.8, 95% CI = 3.9 to 7.1) in those older than 70. Conclusion: The profile of migraine changes over the life span and suggests three nonexclusive profiles. In many, migraine remits. In some patients with migraine, attacks get less typical, resembling probable migraine instead of full migraine. In some, migraine progresses.

[1]  J. Olesen The International Classification of Headache Disorders , 2008, Headache.

[2]  M. Bigal,et al.  Migraine in the Elderly: A Comparison With Migraine in Young Adults , 2006, Headache.

[3]  R. Lipton,et al.  Patterns of Medical Diagnosis and Treatment of Migraine and Probable Migraine in a Health Plan , 2006, Cephalalgia : an international journal of headache.

[4]  R. Lipton,et al.  Migraine Days Decline with Duration of Illness in Adolescents with Transformed Migraine , 2005, Cephalalgia : an international journal of headache.

[5]  M. Szklo,et al.  Headache, cerebrovascular symptoms, and stroke , 2005, Neurology.

[6]  R. Lipton,et al.  Prevalence and impact of migraine and probable migraine in a health plan , 2004, Neurology.

[7]  H. Diener,et al.  Incidence and predictors for chronicity of headache in patients with episodic migraine , 2004, Neurology.

[8]  V. Gallai†,et al.  Characteristics of Migraine in an Out-Patient Population Over 60 Years of Age , 2003, Cephalalgia : an international journal of headache.

[9]  R. Lipton,et al.  Factors associated with the onset and remission of chronic daily headache in a population-based study , 2003, Pain.

[10]  R. Lipton,et al.  Migraine in the United States: Epidemiology and patterns of health care use , 2002, Neurology.

[11]  R. Lipton,et al.  Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II , 2001, Headache.

[12]  R. Lipton,et al.  An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score , 1999, Neurology.

[13]  J. Pascual,et al.  Epidemiology of Chronic Daily Headache in the General Population , 1999, Headache.

[14]  R. Lipton,et al.  Headache in the elderly. , 1998, Journal of back and musculoskeletal rehabilitation.

[15]  W F Stewart,et al.  Prevalence of Frequent Headache in a Population Sample , 1998, Headache.

[16]  R. Lipton,et al.  Variation in migraine prevalence by race , 1996, Neurology.

[17]  J. Olesen,et al.  Epidemiology of headache in a general population--a prevalence study. , 1991, Journal of clinical epidemiology.

[18]  N. Cook,et al.  Correlates of headache in a population-based cohort of elderly. , 1989, Archives of neurology.

[19]  FRCP W. J. MacLennan MD,et al.  The Elderly , 1984, Treatment in Clinical Medicine.

[20]  M C Buer,et al.  The general population. , 2022, The Eugenics review.